Table 4. Top 10 lipid and gene expression markers associated with oxidative stress and fibrosis1.
Pathway | Oxidative Stress | Fibrosis | ||||
---|---|---|---|---|---|---|
Marker | Ncf2 | Col1A1 | ||||
Association | Feature | CC2 | FDR3 | Feature | CC | FDR |
Positive | LpCat2 | 0.98 | 4.4E-13 | Mcp1 | 0.90 | 4.0E-07 |
Positive | SpTlc2 | 0.95 | 4.1E-10 | Liver Wt | 0.90 | 4.0E-07 |
Positive | MIS4 | 0.94 | 2.1E-09 | TNFα | 0.88 | 1.6E-06 |
Positive | TNFα | 0.94 | 3.7E-09 | Change BW | 0.88 | 1.6E-06 |
Positive | LpCat1 | 0.93 | 9.6E-09 | AST U/L | 0.88 | 2.4E-06 |
Positive | GpGro 38:5 | 0.92 | 2.4E-08 | TG 54:3 | 0.87 | 2.7E-06 |
Positive | DG 36:1 | 0.91 | 3.8E-08 | MAS5 | 0.87 | 2.7E-06 |
Positive | GpEtn 40:5 | 0.91 | 5.5E-08 | GpGro 38:5 | 0.87 | 2.7E-06 |
Positive | 18:1,ω9 | 0.90 | 1.0E-07 | LpCat2 | 0.87 | 2.7E-06 |
Positive | SM 32:1 | 0.90 | 1.0E-07 | Total GpGro | 0.85 | 6.1E-06 |
Negative | GpCho 36:5 | -0.93 | 1.2E-08 | GpEtn 36:2 | -0.85 | 7.0E-06 |
Negative | GpEtn 38:6 | -0.92 | 2.7E-08 | GpEtn 34:2 | -0.85 | 8.2E-06 |
Negative | GpEtn 36:5 | -0.92 | 2.7E-08 | GpEtn 36:5 | -0.83 | 1.3E-05 |
Negative | ω6 Index | -0.91 | 4.3E-08 | ω3 Index | -0.83 | 1.3E-05 |
Negative | TG 58:9 | -0.91 | 4.3E-08 | ω6 Index | -0.83 | 1.3E-05 |
Negative | ω3 index | -0.91 | 5.1E-08 | GpCho 36:2 | -0.82 | 2.3E-05 |
Negative | Pdk4 | -0.89 | 1.2E-07 | GpEtn 38:6 | -0.81 | 3.1E-05 |
Negative | 11,12-EpETE | -0.88 | 2.3E-07 | GpSer 40:6 | -0.79 | 5.4E-05 |
Negative | GpCho 38:4 | -0.88 | 2.3E-07 | GpEtn 34:3 | -0.79 | 6.1E-05 |
Negative | GpEtn 34:2 | -0.88 | 2.6E-07 | GpCho 36:5 | -0.78 | 8.3E-05 |
1Associations between NASH features were determined using the statistical package "Pattern Hunter" in Metabolanalyst [37, 38, 53]. The markers chosen for this analysis were based on the most robust response to the WD within each pathway.
2Correlation coefficient;
3False discovery rate;
4MIS, microsteatosis;
5MAS, macrosteatosis